BioNotebook: Post-Thanksgiving blues for Exelixis, Pozen; Burrill notes tripling of M&A deals in 2014
This article was originally published in Scrip
Executive Summary
Public companies often try to sneak their bad news into the evening hours following stock market closing time on the day before Thanksgiving – or on the eve of any major holiday, really – but Pozen and Exelixis waited until everyone came back to work from their turkey dinners and meals of endless leftovers to announce the loss of a major partner and a bad set of Phase III results.